Previously, our group showed that the interaction of TSG-6 with CD44 activated β-catenin/YAP-1 signaling and reprogrammed activated HSCs into stem-like cells, mitigating HSC activation and liver fibrosis in mice with chronic liver damage from CCl4 [28]. The gene discussed is YAP1; the disease is Hepatic fibrosis.